GX1 targeting delivery of rmhTNFα evaluated using multimodality imaging

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• GX1 is a peptide that targets tumors.
• Fusion toxins offer targeted cancer therapy potential.

Purpose of the Study:

• Evaluate the antitumor efficacy of GX1-rmhTNFα.
• Investigate its targeting efficiency and pharmacokinetics in vivo.
• Assess safety and potential for gastric cancer treatment.

Main Methods:

• Flow cytometry for apoptosis analysis.
• SPECT and bioluminescence imaging for biodistribution and tumor growth.
• CEUS and CD31 staining for vascular changes.
• TUNEL and Ki67 staining for validation.
• Biochemical analyses for toxicity.

Main Results:

• GX1-rmhTNFα significantly increased cancer cell apoptosis compared to controls.
• High accumulation in tumors observed via SPECT.
• Satisfactory tumor growth delay in vivo.
• Reduced tumor perfusion and vasculature.
• Limited renal and hepatic toxicity.

Conclusions:

• GX1-rmhTNFα is a potent and safe anticancer agent.
• Demonstrates effective tumor targeting and growth inhibition.
• Shows promise for targeted therapy in gastric cancer.